Necessity of Lysophosphatidic Acid Receptor 1 for Development of Arthritis
Yoshishige Miyabe(Tokyo Medical and Dental University), Toshihiro Nanki(Toho University), Masayuki Miyasaka(The University of Osaka), Hiroshi Ueda(Nagasaki University), Chie Miyabe(Tokyo Women's Medical University), Junken Aoki(Tohoku University), Yasunori Tokuhara(Kagawa Prefectural College of Health Sciences), Aiko Takayasu(Tokyo Medical and Dental University), Waka Yokoyama(Tokyo Medical and Dental University), Yutaka Yatomi(University of Tokyo Hospital), Harald M. H. G. Albers(The Netherlands Cancer Institute), Huib Ovaa(Leiden University), Ryunosuke Ohkawa(The University of Tokyo), Jun Nagai(Nagasaki University), Yoshiko Iwai(Nippon Medical School), Nobuyuki Miyasaka(Tokyo Medical and Dental University), Masahiro Jona(The University of Tokyo), Shin Fukuda(University of Fukui), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 83
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
LPA Receptors: Subtypes and Biological Actions
|The Annual Review of Pharmacology and Toxicology|2010|851